Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
![](https://i.abcnewsfe.com/a/5130ddfd-a1dd-4e33-83f2-71735b54aa25/wirestory_ca026922525a9e3abb1b75d329628bef_16x9.jpg?w=1600)
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast...